Friday, June 05, 2009 11:43:02 AM
Jun 5, 2009 10:11:00 AM
Email Story Discuss on ZenoBank
View Additional ProfilesFT. MYERS, Fla., June 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM) today announced that it will present at the Fifth Annual Noble Financial Equity Conference at 9:15 AM EDT on Monday, June 8, 2009 at the Seminole Hard Rock Hotel in Hollywood, FL. Robert Gasparini, the Company's President and Chief Scientific Officer will give a presentation regarding NeoGenomics' market positioning, financial performance, and strategic direction and then answer questions from the audience. The presentation will be webcast LIVE featuring high-definition, streaming video and PowerPoint slides. Access is available by logging on to http://hosted.mediasite.com/mediasite/Viewer/?peid=a11b62efcbec4c8f90dfa8f3ca8d3cd8. In addition, a portal to the webcast will be available in the Investor Relations section of the NeoGenomics' website at http://www.neogenomics.org/investor.asp. It is recommended that interested parties register at least 10 minutes prior to the start of the presentation to ensure timely access to the webcast.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.
For more news and information on NeoGenomics, please visit www.IRGnews.com/coi/NGNM where you can find a fact sheet on the company, investor presentations, and more. Interested parties can also access additional investor relations material, including an investment profile and an equity research report, from Hawk Associates at http://www.hawkassociates.com or from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/.
About Noble Financial
Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms - uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences - 2009 marks their fifth annual - allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 25 years and has offices in Florida, New York City and Boston.
SOURCE NeoGenomics, Inc.
----------------------------------------------
Steven C. Jones
Director of Investor Relations
NeoGenomics
Inc.
+1-239-325-2001
sjones@neogenomics.org; or Ms. Julie Marshall
Hawk Associates
Inc.
+1-305-451-1888
neogenomics@hawkassociates.com; or The Investor Relations Group: Investor Relations: Rachel Colgate
+1-212-825-3210
rcolgate@investorrelationsgroup.com; or Media Relations: Janet Vasquez
+1-212-825-3210
jvasquez@investorrelationsgroup.com
Recent NEO News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/13/2024 08:08:11 PM
- Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month • Business Wire • 06/13/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:11:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:10:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:09:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:09:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:08:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:07:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:07:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:06:32 PM
- NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management • Business Wire • 05/28/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:07:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:39:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:39:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:38:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:38:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:38:09 AM
- NeoGenomics Reports First Quarter 2024 Results • Business Wire • 04/30/2024 11:30:00 AM
- NeoGenomics Announces Senior Leadership Promotions • Business Wire • 04/18/2024 11:05:00 AM
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 • Business Wire • 04/09/2024 11:00:00 AM
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting • Business Wire • 03/27/2024 12:30:00 PM
- NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report • Business Wire • 03/20/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:26:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:33:35 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM